Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects.
about
Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse eventsRegular treatment with formoterol for chronic asthma: serious adverse eventsRegular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse eventsRegular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse eventsRegular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse eventsRegular treatment with formoterol for chronic asthma: serious adverse eventsRegular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse eventsRegular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse eventsRegular treatment with salmeterol for chronic asthma: serious adverse eventsBeta-adrenoceptor responses to high doses of inhaled salbutamol in patients with bronchial asthmaSalmeterol tachyphylaxis in steroid treated asthmatic subjects.Occupational asthma in salbutamol process workersStudies on the bronchodilator, tremorogenic, cardiovascular and hypokalaemic effects of fenoterol dry powder in asthma.Beta-adrenoceptors in human alveolar macrophages isolated by elutriationA method for bioassay of potency and effectiveness of inhaled bronchodilators in normal subjects.Regular nebulised terbutaline in chronic obstructive airways disease: dose-response studies fail to detect tolerance.In vitro responsiveness of human asthmatic bronchus to carbachol, histamine, beta-adrenoceptor agonists and theophylline.Long term study of the effect of sodium cromoglycate on non-specific bronchial hyperresponsivenessRegular inhaled beta agonist in asthma: effects on exacerbations and lung functionModification of the thermogenic effect of acutely inhaled salbutamol by chronic inhalation in normal subjectsChanges in methacholine induced bronchoconstriction with the long acting beta 2 agonist salmeterol in mild to moderate asthmatic patients.Effect of regular terbutaline on the airway response to inhaled budesonide.The 1990 Lilly Prize Lecture. A way of looking at agonism and antagonism: lessons from salbutamol, salmeterol and other beta-adrenoceptor agonists.Therapeutic management of allergic diseases.Receptors in airway disease. Beta-adrenoceptors in lung inflammation.Effect of beta-agonists and anticholinergic drugs on bronchial reactivity.Asthma control during and after cessation of regular beta 2-agonist treatment.Clinical pharmacology of adrenergic drugs.Beta agonists and the asthma paradox.Salmeterol: an inhaled beta 2-agonist with prolonged duration of action.Albuterol: an adrenergic agent for use in the treatment of asthma pharmacology, pharmacokinetics and clinical use.The characteristics of inhibition of histamine release from human lung fragments by sodium cromoglycate, salbutamol and chlorpromazine.Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics.Beta agonists and ventilation.Genetic variability of the beta2 adrenergic receptor and asthma exacerbations.Beta 2 agonists and asthma.Airway responsiveness to beta-adrenergic agonist (salbutamol) in asthma.Beta agonists and asthma: how do new developments affect traditional therapy?Concomitant glucocorticoid treatment prevents the development of beta-adrenoceptor desensitization in the guinea pig lung.Preparation and standardization of a herbal agent for the therapeutic management of asthma.
P2860
Q24199079-E460B0B5-482D-411C-AC1D-B678702D1220Q24200353-74E3EEF9-8932-4AD3-AF23-4D0656D9E4B2Q24201048-0EFF41BF-61C1-450A-8234-790C2E12391DQ24202005-3E629213-B795-4981-94BC-65455B230884Q24240282-F7A1D676-3AF3-4325-8DA0-3DE27A0BC9A9Q24241250-FB9FB40B-1B85-4501-B3C3-73AA1C1D195DQ24241453-329A4C2E-172A-4144-8F47-4BB4212316A7Q24241740-8E78D865-A1CC-41DC-91E5-9781464FDA26Q24241960-2E2814E2-FD48-4946-9B50-755B5C5728C8Q28359893-64DD463C-0DAF-4C91-B5DC-BC43C6993016Q33775495-4C251EA7-C4C4-4C0B-AE2D-E7BF430B2900Q33818440-BFD494CD-BA8B-438D-B992-15E12BD84D68Q34345856-484FF680-1B8C-44FF-A4E1-AA4AB854F0AFQ34357341-E7A4BB44-5504-438C-841E-36BCA6628AF5Q34357925-DD9E2220-42A7-4A4D-8E5B-EA60E1BA94D5Q34358611-4ED89C7B-6924-4837-9012-9735DCBDFE27Q34448195-2CD56A98-2E41-4750-A541-255E0300F78BQ36171906-CC971EF0-0976-4F8F-B92D-02A53EE49EF4Q36274606-DC0C71B8-D0BF-4517-A4A2-5B5B612F6F14Q36287143-7B06FF10-DDB3-4505-B722-B4D3E558077CQ36289816-AFEC296D-C539-419E-9396-13836878326AQ36501291-3FD1F028-456D-4450-A44D-A0BE23E2FAE4Q36516893-2C900780-0C80-4ACD-9DAE-E3A975A8745DQ37550543-B27EC06E-CC2C-4512-AFF0-2ABC99ECCD96Q37873679-B1BC2152-95DC-4958-AE27-2F2FB2AD0940Q39464435-FBB2234E-50F8-41B8-A4AD-D52C6F4BC825Q39491549-1F743028-3943-48EC-A367-E4687B522728Q40094533-58DCFA8B-59CD-4741-84CC-4915A80C1419Q40711045-E93A8432-3E18-4534-9F12-2E737FB9D2CDQ40713319-DFFF0334-A03E-48A8-9670-91AB7B177BCDQ41429738-489B4A7F-B86F-4EB8-9A33-A799DC47C9BAQ41813071-CFC17E90-4E78-42F7-B02D-0FCB285F3579Q42199227-39CAADC5-821C-42C3-9A81-2966A4536108Q42511546-AFECA42A-44D0-423F-87E2-2B505496F3ACQ42772710-C310B6EC-0CA7-41BF-9B1C-DF56B63A00F6Q43163485-3A2F2854-83F7-4C8F-9B0E-AA48CE1CBAE6Q44736780-D6B3868D-EECF-4D36-83D5-574F4D63CF13Q44850007-5AE59E16-4FBE-4DE6-A8DB-9AB59F54DD0CQ46597695-34BDE441-58A9-4F7E-B1A5-E7A5DA4B99C7Q46898611-42C8332A-D6AF-4450-9EA1-2F9994744D73
P2860
Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
Airway response to salbutamol: ...... topic, and asthmatic subjects.
@ast
Airway response to salbutamol: ...... topic, and asthmatic subjects.
@en
type
label
Airway response to salbutamol: ...... topic, and asthmatic subjects.
@ast
Airway response to salbutamol: ...... topic, and asthmatic subjects.
@en
prefLabel
Airway response to salbutamol: ...... topic, and asthmatic subjects.
@ast
Airway response to salbutamol: ...... topic, and asthmatic subjects.
@en
P2860
P356
P1433
P1476
Airway response to salbutamol: ...... topic, and asthmatic subjects.
@en
P2093
Tattersfield AE
P2860
P304
P356
10.1136/THX.37.4.280
P407
P577
1982-04-01T00:00:00Z